Aehtrancc Sheat ll Abbott

';',;;"ft\ rt E s'.t'tt E s t *\ rr' L't<I't' I c r\ L {' *\,,

Inlrrnoora Ancldrodcs SlnqleAcentr BalancedAnesthesiala
Vgg.aCCfS-cOm l-J Anesthel
Con5ciou!
Sedationor Analgesia
nnuc||o. -ffiq r tocbrruDu\r Tn.,rFNANl LoADINC DosE MAINTENAN

- dexmeddomidine /Pr€ced€.ra l an alphar adhdepld remsl N/R I hce^e over l0 min I ncg/reover 10-20min 0.2- 0.7'ncsAgrtr
0.2 - O.1 tuetxg/tt
F etontid^ta (Anidae) O.2 0.6 nrlq (iI age>10) N/R locYmin for l0 min, lh€n -) 10(') l5 - 2CVmbtu 10mh$en -+ 2.5-7.5\51
F kdeniae(KenlaP) I 2 nr^e (5- l0 tM,?R) 30 100 t000- 2000 l0-50 200- lo00 5 20
E methoheAtsl (Ba'ibFI%) | 2 (20-30 pr 10%) ngtg N/R 1000- 2000 50 - 150 5m- lom l0- 50
a , t ' i ,r, , , ' r: , ' r ,,.,, 0.1 5 0.35.e^e 0.25 1.5 50- 150 0.25- I 20- 100(l0m.q/h n@menrjl 0.25 I
E prryofol (Dipri,raa@) 2 2.5(2.5-3.5
child)ng&e 100- 200 1000,2000 r00- 200 100- Is(yminuntil$diiorrhm -+ 25-'75
- tlrloo(nl^l (Pentothal"2.5%) 3 6 (30-40
PRI 0%)ne{r N/R 2000- 4000 200-300r )cmm 30-7othercaie' 500 2000 30 80
l i l l iY rt rnil I l/r , t r l I 30 - ?45 ncsAs600-2mm(q/& bhl) l- E 5U- T:U U .5-J to-zt 0 .? 5 - I
€ l (n lrrr l ' \ f / ' i r ; , 5 40 mcs&e150 l50m(!/r9lori) 0. 1- l 5 15 0.03 0.1 l-6 0 .0 t- 0 .0 4
3 rf"ri f (nlnnilll , , 1 , , r I- 3 rcl^srli' 0 murdeqiditl) N/R o.5-2 0.05- 2 o'e'1060j€c)
0.5 - 1 (intuai 0.025- 0.2
\rrl(. l1rrl| rl, \ r r , , / r , 2 l0 n ca &s1 1l0
5 m a /r o o la ll 0.05- 0.1 o.25 2 0.01- 0.M 0.1- 0.5 0.005- 0.0r

doleEWndlierrndu(l
onwithdnorher
agenr5.Approvedforonyih0nprocedure5dtrelornhblionoi(o((olFrordlyntheli5
[alfgnrnt ltDerdErmb hotoco! 6..,r' ph6e r@dnqo
f,gtmnrucultr Eloc,|Glt (do6 h' M L k Help. Get Dsntmlene Stop succinylcholineand all in-halational
lV Intubatlng',s^s ChildIntubating Rsl EDn Maintenahce: anesthelics.Hyperventilatewith 100%O, at max nows (> I0 r-mrn).
suc(inylcholine fAr..r,k't 0.6 (0.3-1.1) l-2(3-4IM) l'1.5 0.3-0.530- l5once'kstii' 2. D,fJlxolere (Dantium") 2.5 .s^g bolus fupidly. Titrate for control of
lann'los tM
laryngosytrm 20rebolus 0.1- 0.2 MH Sx's. Max dose = l0ng/ke but sometimesup to 30n9'ke if
..:l-i necessary.Continue Msntrolene for at lea,st24 houni aftet
conrrol oftheepi soder appror. Im8^sq6h
E cisatr$curiumiN,rr(a r 0.15(0.15 0.2) 0.1(^ge2-12) 0.4 0.05 | - 3 tucgkgmir
3. Treat acidosis wilh N8IICQ suided by ABG's, odrrwise use l-2 narae
i doxacurium {Nrrrorra,r'"1 0.05 (0.05 - 0.08) 0.03 - 0.05 0 025
f, d-tuhrxurarirrert.rrrarz,r 0.5 0.6 0.6(0.3Nmnate) 0.51 I - 6 mceas/mi,) 4. Start cooling techniques:Give cold NS IV ( | 5 ml/r-cqlsmin x l).
mctocn.ine(M?tubine ) 0.3 - 0.4 0.2 - 0.3 0.28 tavage stomach,bladder,rectum and womd with cold NS. Surface
V
g rnilacurium'{.ltir.r.rrrr') cooling with ice and hypothermia blanket. Monitor for overtreatment.
/ tn ",.ru r'r 0, O.21O (0.15 . 150- 25) 0.2
0.25) 0. 2-- 0
0.25 (age2
25ias e212)
12) 0 8 5 - 15
0 .08 1 5d.e^gnin
d.p&Enin
' ' i u"""' i" ' ' ' 5. Dysrhythmias usually respond10Rx ofacidosis and hyperkalemia.
pipecuronium {irll,.rr' / 0.07- 0.1 .04- 0.06
0.04 (ageI 14)
0.06(ase 0.05 If not, administer standard antiarrhylhmic with exception of Ca:'
lo<uronfimt (7.rnlurn' r 0.6 (0.45 - t) 0.6 - 0.80.8tr'|) 0.6-1.2 0.3 o channel blockers (may cause hyperkalemia ard CV collapse).
0.1 0.3-0.4 0057 0.8 6. Determine and monitor end-tidal CO.. arrerial, cenral or veno$ BG.
K*/lytes, urine outpnt, FIIP'IT and ea:* for ba,selme-Repeat pm.
l . Fo rplm ngor d056.use15%of[0,. ] 5mmprort0ind(ion 2. 005e5. mantenanre
b0lu5
dosrnqu5e2040% of[D",
7. For hyperkalemia:hyperventilate,NaHCOl, Insulin lOU in 50 cc
ncU€tsal of Xouromuicultl BlocNodo D50 and titrale to serum K . lf neededadd 2-5 nsrg of ( a('1,
i rl i, t n, r. 0 . 0 15 - 0 .0 3 .e ^ ea n d 0.5-l lv 8. En\ure urine ourpur of> 2 murBrn\ri$ lV fluids and/or manriilol
'ns& e (0.25 sas) or furodemid€ (l msas).Consider CVPor PA monitors-
{f\r1,r'\ t rof.rt( / /l,r,j,r, t , 0.Ol-O.02^grs and 0.@0.0Ene^erv
9- Suddencardiac arrestin childrm after $urcin]lcholinr should b€
hdopcfduc nedacd]o'|a ,'rtie",ott6, Ae'e6.t) treatedas acutehyperkalemiafirst. Give CaCl, with above Rx (#7).
acetaminophm (Iylenolo) 2G40 ncas PR.5-15ncac Po
^D.tsc}fua Presume musculardlstrophy and consulr neurologht.
- 'ubchnrcal
; l ,ri , ' rt ' hl| D,' l ' . . . 0 . 5 - 2n g ( 0 .0 l- 0 .( Xd e ^ !) Iv: l4 m g r M MHtmergen<y Honliltr (8t10)
6449717or001I 115464i079;Wehrite: wwwmhar! or9
ke t orolac lf o r a d d / ' , l 0 m p l0 .5 m e a !r r \r 6 0 n e ( l m s^ s) lM
'-; ralbuuhinr r \rpar,; , 5-10 ng(0.1-0.3 neAs)tvn[.n6c lnhthdontl AncadEdc3 MACtvoie6lr Vapor Pres. Partition Ceffcients
dexamethssone (D€cddrono) 8 nB lv (0.25 ne^e child)
dol*{to' (AnzetieP) 12.5ng rv (0.35nste child age2-16},rs.to mex 12.5.g)
0.625'2.5ns ( l0-20nce/ls)IM/rv
0.1-I Dglv over> 30 s€c.(10rcs&schild> age2)
5-20ne(0.1ne.'tre)pownv (N givenover l-2 min)
4 meIv/M over > 30
U , Zn g Ivq m m ( u p to r n e m a vJm ln , J In ema lultarr-) 1.7-1.426-2.12.5 3.O 3.3
sevoflnrsDe 160 0.65 |.'7 4'7.5
0,1-0.25 ."sAg rv q 2-5 min to dax of I meAs
0.1 0.4 ns [M,a v/sQq3min ( I l0hcs,ftechild) foreyeopen
nqon(omnrand 05MA(
{ilA(-awake}ure
lutooomic / GanloraSq rl llnrgli Mixture/Con.entration Clinical AdrenergicRe(eptorActivity Hemodynami<Effeds'
IV PUSH IV INFUSIoN DILUTIoN I.]NAL MUI-TIPI-IER] DUTAI|ON DiEcI IIdiB.I AIPhaAlpha Alpha BeT! &!a CO Inofop HR MAP VR SVR PVR RBF
---------l'ffi";-1- '-
Ia.!tue Dose r*,t"mo r",::so.rr corc-x Wi=Eate llv j 0','.d,r"r',1
IrhetlrlephriDc \,, , /,,, ,50Zoomcs U.l5-0.75 20ie 80@c/lnl tr.U/)=U.l <)min r+ l+ r'r++.0 0 0 0.1 0,T dr& TTTI T't'l TT 0.J
-E norcpirreph rhrerl, r,,r'h,,/ rN/R 0.05-0.5 8-g 32msrnr 0.18?5=0.12-l0nr l+ o toJ f lraa 11 T11 TTT T1 J.tJ
E (pincphrim1.1./e,r,/iu' 2-t0-cE lld.* 0.01-0.03 4-s l6ns/dr 0.11254.03 5-l0nm ll+ + r+ ]+ TT TT T tt T 0.J T
F p>d 0.03-.0.15 lns 4."sid 0.45=0.03 1.B +# to tt tt T 1 ToJ T,o Jo
E "+B 0.15-0.5 r+ r+ 1.0.JTTt 'f'f 1 T 1TT T .tJ
$ cphcdrine 5-10.9 N/R 3-10-i' * * + r-+ ? ll lt T tt TT T To..l
; doprmin'rrrrt,l,rr I N/R renaiaose 0.5-3 200.e 800ncs/nl0.375=5 <lon,n * 0 ]+ D0p,mm4((tpro,imldd 1 0 0 0..1 T 0.J 11
Fd@ 3- 10 400ne 1. 6ne / n l 0 . 1 E 7 5 =5 + l +? +r +# l l f I t T J 1 .0 T
f, ,r.p 10-20 800ne 3.2ngnr 0.09375=5 +l+,+ r |+1+ T.o..lT1 ll T T 11 11 I
- dohutarnineI lrlr./rt r" / N/R
9 2-30 250ne l-gr'.t 0.3=5 < l0nin * 0+ ? o r-# ++ It TTT T 1,J,0J o,l 1.1 o.T
E rsrrurorrfi_nol,/rri/,r, / r 20-60ncr 0.01-0.5 2^e 8 mcE/mt 0.1875{.025l-5nii 1+ o o 0 |+l+ 11 fT T11 1.1 ., Ui Jr 0.t
E . njoorrssin rpirr.r rrn I Adu.lrDose 0.01-0.06urrh lmu 4oonutu N/A l0-20nin aitdu'air(m( Dfi) J
l*modrFd'(d{trh5{r0(srr0d( 0 ff 1f 1
'.-
J lnoc'nocoPr Ai i 5-20 100^e 400ncdnr 0.75=5 0.5-2hr 0 t 0. f 0 . J J
? mibbotelPrinacoP) 50*** stwlv 0.3?5-0.7550ng 200nctsr 0.15=05 0.5-2r! o 0 0 TT t1 0,1 0,, J tJ J.l-
iiiiiiA li4i;t?ibli h:?-t 2.5-5 meq l5min: max 20-40 ms(or 0.2-0.5rp^s) 0 rtmrdlron 0 0 1,0 dle rfld .r* .rt JJ
-{aidi .t J1
:,n Fostvcenne t&trrara 25-50me 0.1-7 50ng 200rcg,,t'r0.3=l 3-5 mit{mrdiraid .l Trda 1oa J
E'iifti#iiii(#td{tlwi i ft aet. 0.5-l mce.rt<e 0.1-10 50me 2OOfrce^ir0 3=l -i" dnd{n&emo6r.rlndro,(iyl o.T TFrit 1t(le} .l.tJ !J o-l
E1(iiiii&ti{6fr6fr (A:f;iii#I. l - 2 0 m g 7-85 250ne l.y''t 0.3=5 5-l0 Di! dl,l6rib&rBi0r$( @drkgddbuodli 0 0,1
E llllli,?€m ( Co rclizem' ) U.Z)/ 0.J)n€Ac l_J l( r um S zt( , m c Ahl U .l l =l 0 0 0 0 t.oJ tt0. rJ
E ni(Irdnptu|€ (Cardenco ) 0.5-2-g 1-4 25^e l00rcernl 0.6=1 lG15 tuin 0 o 0 0 0 0 0 I O O JJJ o .IJJ
E nife,dipine (P rccardiaa ) 10'20*s/ks l-3 50mg 200."e/.1 0.3=1 4-12h' o 0 lfiE} TrcfuJJ O.J UJ
i leram|nl /Co./rro) 75-l50ncrac l-5 50m! 200msnl 0.3=l +6 bt 0 0 0 0 0 0 0 ! I J .[ o.T !t
eslnolol ( arerlbloc') U.)-l mc^e )U-J(,U 2J8 0 JJ .t .tJ .t
bM'^bl (Nonndyreo) 0.1-0.25 nr^s 2 -8 rcs^nin 24tu - 0 0 to J o,J lJ
metoprolol (Inprcssof ) 5'8 hr o J]JJ t
0.5-l nr. o'q l-5.r l{n' o o ; .IJJJ J.0.1
''tunr'Dolotrll,demP)
amiat4^fone (Loflarne- ) 1J0 ne lv tanii. JOUnRnef 6 horr:.)4U h!. r!tnin. 18hour\ (+od(bdkd
amdlrhylhm.(dr,
f kflxl{ifxr lYr/a?rr. 'r I-3 nshs 2G60 1g 4nslnl O3-JO l5-30min aiMr'itli1)mkosnbr
i+d0{r.de(.1dqorii&ri!.) o,t o 0,,
procAinemide (Pron€rnP) 500.R-- Jo lcinD5W4ns/d 0.3=20 2-4b anoqaryhh((&,i
ptu
oi$ n 1l dep0r
aro, 0 o T o.J o.J
^,15-gJ 'adeudin

LEctto:l0n8d. 7/lOpioid
Ant.qorb
Pediatric Code Further dosing . Indications Aduh ACIS Furtherdo5i n9. I ndi < ati ons
adenosine 0. | .!^g Double . d repea(edose il ro ellect 6 then l 2/ l l mEN push I dmgforP S V I D oesr.)/ conl e :r(rrall i b/l l uuc r 0r V l
amiodarone 5 me,,k8 rvno pu.h give over 20-60 min for tachycardia NmiodNmne 300 ne Iv initial for Cardiac Arrest. Max cumulative dose 2.2 I M24h.
l0 20-re*e q5mi l m a x.m in im u n 0 . I s. thcn l 50D sq3 5nl i n I 15*sr-.r\ for stabl et!'i decom pl c i uc h)c ardi a
Ixfibrillation 2r^einitial - r 4 JAs x 2, Repeat after each med.
then I msI v q 1-5 ra 0.04 ms^sma). do\e. as) nole,ryEA-/brad, cardia.
^For (J .hafl hl o(k U D
0.5 I ras tor c.rrdi0vet\io|. CaCl, .'I l ur .r'di ], rne.r ui rh K .l ta.',r
'...ql unl |Ip|l r
rpinqrhrirr 0.01 ns,&sq3-5min 0.1 nl^sof l:10.000. May T 2"r' dose. diltiaiem 0.25 ngng over 2 min after 15 min, 0.35 nser; infuse at 5- I 5 ng/hi,titrate to HR.
glucos€ 0.5 I s/k! 2 -l D'r/l.!of D25. Givc r/.,r hr | ql 5 rnur lbr VF/pulselessV'L as)stole,.ll)d PEA.
ir(trt(xinf I me.,tte may.epeat x I afl€r lonin. 2--!I 0 nce/nin Not indicarcd fbr cardiac arrest. Tiirare to adequate HR.
magnesium 15 50 D,e.&s
tv'lo fot lorsdesde poinles or hlpomagnesenlia | 1.5ne/k!i ni l i al 0.5-075-s,xg.rfi cr5 I0mi n:forpc rs i roD l V F/V T
NaHCO. I nrq/ke Use only with ventilation. Give rlonl,r.:. 30-50 hcs&g/nininfusion Max total dose 3 ms^e.
Vo l u me l0 :0 Nra! r \o to n ic( cr tsla llo id ) magnesi um I 2eh l 00N rD 5W i nfu\e al 0.5 l -qr"(forrl ,rsade\.J Mg.refrac l (ny V F).
NaHCO. I meq*einitial ABG;0.3 x wt (kg) x basedeficit; do not mix with
PO Facticc Guidellnest 6tt aset h@hhy pa.ients,etdliw prcEdures) ther 0.5mr.q^rql 0 mi n catechol ami nes of .al ci um saks.hel pfului l h Ik
Clear Liquidsr: NPO r 2 hrs Breast Milk: NPO x :1hr\ procainamide 20n/'inrv infusion maximum lTmgas, l00ns tvp q5m ifrefractory VF/VT
lnfant Fomula: NPO x 6 lrs Non-human Milk: NPO x 6 hrs \ rt\,t)t.\\i n .10l r\4(tFrx I Al ter nar r \ i D r e* ,,r r ,, c n,r c nhl l ( r L J rJ rJ i A l l e rr.
Lieht MeaFr NPO x 6 hrs I tl {Nalo'one, . /i /,:r r ,, ,1', :i fr r ,L:l r ') na!bi 9v ;r !'r i T i nl l . i ri t . j l l i r rli l l r ,l
Medications: Should b€ taken with < 30 ml of water > I hr before
l. !0, ircndpd
l0rronren
n ih0':. .,,t.'.un't'r rtr,.riT,rrt,,rr tu,*uq,
trt..r',onrr,,a
',,
0.5-1ogngFo;0.2-0.3ng& gN ;0.1-0.2ms ^sl M;0.I l v ; l pR
Iluid Management 5 15Nre^eor (5 n.s/t! adults) (l(ll0 min prc op)
MATNTENANCEi 4 nr^s^r -)" Iqkg,2 nstu 2" Iqkg.1nt^.stft renminder 0.1-0.2ms^sIM (45-60 min pre-op)
I lirr Pts > 2A kg hod\' t\ cisht. tukt wt in kt + 10 = maint.nant e itl rt/h ) 1.5-l ncr,l gnl trana\al (tN )
DEFIcrr: Maintmance fluids per hour x hrs NPO without hydration. chloral hydrate (Ir'otec!) 65- 100 ms^g po/pR
R eplac e/ : of d e f i c i r l n 1 ' 'h r . /,in l' ih r : clonidine fc.rr.{rr.rrtl :.5 pR/r\:.i n.s,k:r'o( 105 l20 rnin prc op)
-.s^s l a]6po;8-l 0P R ;0.25-0.75rv ;3rN
BLooD Loss: Replacewilh LR: ^3i r2 blood. colloid, or He6panoiMdl0.,/'q/r,!lI tol ketami ne((el dl drdj
l: Dd
to ' a 35nsasl
I HTRD-SpAcD or INsF:NsrBr-E LossEs: methohexi tal(B rerndl 'l 15-3(l pR(2 l (l C .sl r).6 l (l rN(5tt
r \l n)
pentobarbital (N€ftb talq) 2 4 ns/kg -s/ks
po'pR/rNi(or secobarbital S€c.rndID) 2h ple-op
lntraabdominal, Hip: l2- 15mr/krrr l'' hr,6 I 0 inL^sartherealier
Extremities, Intrathoracic (Noncardiac), 6- I 0 nl{8rtr thi opentsll P cntuth(l r) 20 30r,!a!pR (:.5 l o'ri sl n)r I l r*^rr\
TIIRP: :l-6 jrl/k!/hr*walch for \udden expdnsbn liom irrigant P ri D l N { C ocK ratl : l 5n.e^r.ketami neJl .5"'!,xr,-:',,r.!',,1,,r. l 0r.g,x ! for db_i ru
'lrardmat Mild 4 nrks/f, Moderate 6 nttusrtu.Sererc ' I nttusxn P E D FOC o(K TA IL: 0.-t-0.5np/k!.ketami ne.l 5 n!tk!. , i ,r ,..1, l 0m.!/k !l dr(!)qn1g
LRt\t OITTPUT: Adjusl fluid\ io maintairral05-l I fnalrn' i"to'l,ocar
'n4ie/hi: rnesthetics Rerative pK. onset Duratron (hiil Toxi<Doses'
Endotracheal Tubcs/Airuay fianagement
\' \r/r ,1 r' Br ..r Ir .r "L ' l\4 \.lr l\ | ..,h1'rr"t','n.,i ,r' | 9.1 raprd U .J-l l- '- l LnrumB
Prematur€ rs./ *2.53.0 oMil
(.1-2.5 8-10 N/A :,,rrir. I rapid Nn 0.5 I 200rng I 5I N/R
Te r m-6mo./2.Jlhl * 3 .0 lM il I 0 ll #li2- . 1. . : : t r i {r i n r , \ , , ) , '. , ' I 8 - 9 r a p i d 0 . 5 - li r 0 . 5 - 1 5 : 0 . 5 - l r 800m9 8 l
6 -12 rno.( 5-7 k i * 3 . 5 / 3 . 0 | M il 1l # 1 \l\2 - 1 t 8 8.6 sl ow l -( , ,,) l -i 100mg I i .5 i
4 nrS s l{ il 12 .l r ' ,, t , r ', r ( , r r , . 8 8.1 mod l5-2.5 3-.: ', 2
+1 1 7 5 / 'r h C
f 2 -2Omo. , /,.. ::-
2 y@ rs (12 k * 4 . 5 / 3 . 5 1.5M il 13 # 2 : 2 - t0 c t r 1,1,tr,,,,,, 6 7.1 rapi d N /R :.5 I :r I 12 .100l n8 6 \
.l ye ars l/ . / h) * 5 . 0 / . 1 . 0 I M il l,l *2 i 2 l0 - i: In i ,nri n( . '. ,.". 2 7.9 rapi d l -l -5 2-| l -l ' 500mg 4.5
6 y€ s rs (l8rs ) * 5 . 5 / 4 . 5 2 M iVM a c 15-16 # 2 :2 - 1 4 ,, ,i r f,r'i .rrrl ,, : 7.6 mod N ,R 2 r 2I 500 nrg +
* 6 . ( 1 5 . 0 I M il,^ Ia c "r
8 ye anil2. / r{ ) 16 11 *2 /:a 1 1 4 - o rnl '(ai rx i ,j ,',,'' i 2 8.0 rapi d I r: 1.5.r' 600 mg 6 ')
1100years (. 10t s ) 6.5 2 3 M iyM a c 17-18 # 2 t/t;2 - 1 4 - r , t)i ',!r',rj ( 8 8 | mod 1.5-25 l -l : 9-l l 1.5
1 2j cars ' J ri. , , r\1 r u \lu . li:U d i. lt,..

.\d ull Large - r , / d u . , L n o . o I I M iyM r '- " 'r s{ In

--
Pregnancy 6.57.0 l-4 Mac io iu rvn llemodynamic Formulas
,rrr,,rt'N.c.ir
Adutf rnt'nh
Nasaltntub. A <-7 s 3-4
6.5-7.5 ?-r MivM,. ..r.r ?
MiyMac add 2 I1 N/a
N/A Variable
variable Equation
Equation Normalvalues
Normalvalues
ffi
tl l:r l z e r ' I r-{u !a :+}rr't ' nelpnl r .l )
Cardrac Index(Cl' CO/BSA 2.8-4.2
lmin m
' SL r o lL'\"l urne(S vr C O/H R x l (X )0 60- 9{ lml .hc al '
l)istance at lip (.i ) = I ! SiTe (.-). Nasal = ,, ..
,.;,-
",,-- Strokeindex(SI) SV/BSA 40-60rnl.beatim:
Estlmatlng Blood Loss McaI)anerialpfessureltrlAP)-.,-. HC
syst€micvasculatr€sistance (SvR) P,,ll"l"li'*::t i lll:\c^Pres lk:9i*'l sec'cm5
900 1'100-dynes
Slc.noN t,oasl:s:Bk)odin sucrioncaristernrinr$irigarion t(MAl qVP + COlx-80
\) r lcm i c \r\rul rr fesrstance i rdex (S ^,._,
V R I) I(MA P C V P )-C Il x80 1900' l ' 100d!
Sp oNG Et , os s E s ,B L o o D S o A K E D:Ra vte c= ts ,.t,i' p = x0 , j
rrM^TEDBLooDVoLUME(EBV) Eilmonaryvascular resistance (PVR) [eAP - PCWP)-i CO] x 80 100-250 dynes.sec.cm
obcsc 60nr&8 premie 9o-t0omL,kE A,lm.'nur)\c{uh, re\i.t3'rcenrde!,j:vRl). ,r5 225dlncs scc'cm'
RightvenricularsEokework index(RvSwI) lJff-.T}'P:f.ll'^130
0.0136(PAP- cVP) x SI
Ilrin/Female 65 rerm go-90 5 9 g-m bearr.m:
AdulrMat € 70-vr!
nn ; -;e-
< ly r , ?5- 80. 1r ; I r t i r u n n i e u l c r 't r ^ t ( $ o r k i n d c( Lx V S WI ) 0 . 0 1 3 6 ( M A P 'P C WP ) x S I 4560gmbeat m:
Muscular
"'-*-'* 75
'- nl/ke
^^" l-6Yr,70-'75
'" '" '''=!!,,,,
-" nesnlrrtorv Formulas
-- lbbruuhllon.
AI.'..$ABLE BL(')DLoss= (Hct,... , Hcr.",,.1-:.FP)/Hrt* v"ir"[i"Eq""ii"" Norrnatvatues BSA Body
=
\b l rM l li) lhA N s F L s r i ( H c l $ rfa(e
area
. . Hclf... ) EB\/He r
.. e i"..f* .-i ye." ,.r".. l l OmmH g(fi o.=0.21) BMR Ba5a^4etrboli(Rale
Prcoperatiyemedlcatlons(d,adossJ CaOr Aferlaloxyqencontenl
\ ) r ,,.,,,, i t,, \' ^,1.:11:l?"j.li-.t-:i-^119?.]l]i
Alve o l ar'ai enalox) gm gradrmr' !01 @r''" < l OmmH g(Fl O-=0.21) Cc-O. Pumol]arycpr aryO aonienl
r-+'"*i^,n'' ' ^ l^'ll; ,t^19^^,1""9 ratio (a/A ratio) >0?s
h{'nrn'Hyr'ro - r"r CO
CvO,
Cafdia(ourpul
Mixed venou50.rontent
r's.g,n. iri's "'-r, THif j?il%:A'en C-VP (enlra
i\4ein venouspres5ure
l5'30nsro..,. a fractronorrv 0.33 Oxylendelivery
Phv;td;.;;';;".;"s
' i l n i " , p' r.r PO.
l ^ r' :i .l5r r" pco,/r' a(n D.l 0xlgendeNery dex
Aneriatoxysen c'ontent - 2l ml 0,.100mt' EO, FraclonInspr{ed
oxylen
:";:]llT,i}|X
-' -,H h r.i h \ro roo,-P ao,n.ontr' ._ .^' HR Hearlrate
; r ,.;;;;;.;; i " i l ' .(' a o
Mixed'"enous oxygeo content 15mlo1.100ml' MAP lveanarteialbloodpr65ur
; ; ; l..1:;;:,...
; i .i -0 .0 ;;,,,;,; rr) - ' H h I rh sru l on' -' P \o ' nnol l , _ PB 8aoftt' ( plesru
re(760nimH9)
, : ,,:' ,.,
.(
Ar r e n al -venous oxygencontentdi fference 4-5.5ml o..l 0oml l PAP pulmonaryarery
lvlean pn5s!re
- ' a - *O . _(.J(J (.\U hro |1.0vaportension(4hmHq)
seco barhilal/ p e n l o b a r h i l a l 5o-200oeponv ,_ :_ ::,_._,::, _'_j "
tii:fHl:lp-f' plFiolosic) shuntfraction <5% PaCO. Arteia C0lension
diphenhldramine {11.,urlr\'t' ) 2sso.."ui"ii' cao )/1c(-o''cto ) o' P(. a)o':10 r' '"' l PAO,' Aiveola(OlFnsion
hydroxyiine (fisrarilo, Aroio-9 zs-too to.i.s&o ponM ;Q:/,$t=,1:.9 (000r0^'r': "'
prometh^zine (phenerso,'r ^e
r:.:-so ro.oi"oli'l:J;;;;;-,',,'.' ':- .^. Paq A(eria 0.ien5on
-, .:......:
il
Or \se 9:,lli,-lli
n conrumpl i onor -pAo
Fi ck eq tor C O 35n O kg'mi nrr@B MR t PCWP Pumonary pre5
cpiii rywedqe
me tc lopram id e I R p g l d r . , 5 - 2 0 ,st0 ' (r)- 'c'-o
cimeridinc, /,6,,,a,r', cio ' rri " \o '(ro kCO. l4rxedexpied[0.tension
"',, '',1'",'XX-'"ffiT''" .i.b..'.? l.!:,1 llGl'10 lmrn ' m "' PVO] [4ix€dl/enous0,
tenlnn
fam(nidine(pepcie) 20,+0.: polv Sll,!-c "_9.- l "o,) '
ranitidine('znntuk'") 1s0-30d-rr'o.50l00ru,r\ ^t-.1f:l: "' Qs/Qt nrrapulmonary5huntfr&
"Ile'":9']]:J..'l:-"p""
Do:,=c'o((3o.I l0 l0(xjml nrnr SaOr Arcia0.siturallon%
sodiumcitratefBi.irra!) t03o.rpocz+tr qo
cronidine,,,/d,.,,\. . r5-.,. ,' i; SnO, filixei
Venou50.Salurduon
i9:l- extraction
oxygen fll1.l9-l-.,1"ratio 1i'i:::"'r
22-30 % '"''' ''' VD Dead 5pdceqa5volume
wBere rcd{yel10rossureiral+edrugdosage5fi l0rlhn$[derer.edr n&odwtf o. ER =( V O . / D O . ) x 1 0 0 . , / l ( C a O . C r O . ) / C a O x- l 1 0 0 Vr ldavolunr
R(i)rFendat0r5tIme0lpLrb(a0r Ih reader: uqedt0{Ne.ltrpdruq 5pi(aq me l d) 0)(on5umption (mrnLrre)
. d.,0 r c0 ,q ., p ,r 0 " d q " jp^do ..r ..,.ds r r ,r , ( fl l r !.r i x l i r i r J effr ey C us i c k M .D .r 'l i l fr L n r qhl ) ,i r ,r r r L ,l ar r 0l ber .p,D du( fd yO,
"ao !1tlr r r ,lr r r r r :!.i ! | r w w w .aaar 5.c om r i r fr t r r nn,!i r 0r i r r $i i fr 0r nr al 0rP0.l pl\ T eav dr l rdb voll ll.(onluorplron
rndex
o .:oe 'e tl t'" re ? m 1o